Information for Media Partners
International Journal of Drug Regulatory Affairs (IJDRA) is a broad-based journal giving leading international coverage of all aspects of Pharmaceutical Sciences. It publishes high quality original research & reviews. By advertising in IJDRA, you can reach the targeted audiences worldwide. Your product information disseminates internationally with comparatively low cost budget.
Regulatory Affairs professionals /Scholars, Patent agents, IPR / F&D / R&D professionals, Pharmacologists; toxicologists; Pharmaceutical researchers; Pharmacists; Clinicians, Analysts, etc.
Company: UBM India Pvt. Ltd., Andheri (E), Mumbai, India
Event: *7th Annual Global Pharma Regulatory Summit 2018*
Venue: Berlin, Germany
Description: To bridge the gap between external requirements and internal obligations, CPhI India brings to you the 7th Annual Global Pharma Regulatory Summit 2018 scheduled on 30th May, 31st May and 1st June in Mumbai focusing on the clarification and interpretation of the most critical regulatory guidelines established by CSDCO, FDA, EMA, PMDA, Africa and CFDA
Event website: http://www.pharmaregulationindia.com/Media-Partners.aspx
Contact: +91 70453 50749 (Jyoti Jeswani)
Company: marcus evans
Event: TMF and Clinical Operations Quality Excellence, 19-21 March 2018
Venue: Berlin, Germany
Description: This marcus evans conference will help clinical operations and documentation professionals to develop better practice and methods to improve safety and performance in clinical trials system while supporting more efficient inspection readiness.
Event website: https://goo.gl/mz1TWC
Contact: MeliniHadjitheori, +357 22849308
Company: ExL Events
Event: *eRegulatory Submissions Summit*
Description: Taking place July 10-11 in Philadelphia, PA, ExL Events’ eRegulatory Submissions Summit will feature in-depth discussions about best practices for the electronic submissions process and protocols for IDMP, RIMS, global and regulatory submissions. Attendees will hear obstacles submitters encounter during the preparation, filing and management of regulatory submissions and ways that industry leaders are overcoming those challenges to deliver a successful electronic submission.
Event website: http://exlevents.com/eregulatory-submissions-summit/
Contact: +1-917-242-3897 (Kelly Osmulski)
Company: SELECT BIOSCIENCES INDIA (SELECTBIO)
Event: *Novel Formulation Strategies*
Description: This event is Scheduled for April 12-13, 2018 in Mumbai. This event will include discussions by Pharma Industry Experts covering issues like Solubility & Oral Bioavailability Enhancement, Modified Release Formulations, Difficult to Formulate FDC, Water Insoluble drugs and 505(b)2 – Innovations for US market. The organizers envisage to bring more and more overseas and industry scientists as speakers.
Email: firstname.lastname@example.org, email@example.com
Contact: +91 76961 25050 (Farheen Zainab), +91 76962 25050 (Maninderjit Singh)
Company: COMPLIANCE TRAININGS
Event: 1) Live in person conference on Computer System Validation
Date: 6-7 Dec,2018 (Indore,India); 20-21 Dec, 2018 (Hyderabad,India)
Presenter: Mr. Kalpesh R. Vaghela
Event: 2) Live in person conference on Technical Report Writing & Statistical Analysis
Date: 6-7 Dec,2018 (Mumbai,India)
Presenter: Dr. Mark Powell
Description: This new 2-day Seminar on Computer Systems Validation will explore proven techniques for reducing costs associated with implementing, using, & maintaining computer systems in regulated environments. The FDA performs GxP & Part 11 inspections, with an updated Annex 11 regulation, & companies must update their systems and processes to maintain compliance.
You will get a full understanding of how to perform Risk Assessment as part of the step-by-step risk-based approach to computer system validation. This distinct approach will help minimize project time. You can ensure compliance with QA, FDA, and clients.
Event website: http://compliancetrainings.in
Email: firstname.lastname@example.org, email@example.com
Contact: +91 8867363146 (Nilotpal) / 8041700521
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:
- "Pop-up" and "banner" ads appear on a random, rotating basis. The advertiser has no control or input over the pages where their ads appear.
- The Editorial Board has full and final approval over the content of all advertisements.
- Advertisers will never be shown any manuscripts or other content prior to publication.
This Journal carries an advertisement, which generates income, but journal not be dominated by advertisements, and advertising must not be allowed to influence editorial decisions.
Journal follows advertising policies as per International Committee of Medical Journal Editors (ICMJE).
Advertising and Special Services Contact Information:
Dr. Jitendra Badjatya